Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports

Higley C, Hsu CC, Smith C, Nadella S, Lalos AT. Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports. World J Hepatol. 2020;12(12):1341-1348.

Publication Type:

Journal Article

Authors:

Higley, C; Hsu, CC; Smith, C; Nadella, S; Lalos, AT

Source:

World J Hepatol., Volume 12, Issue 12, p.1341-1348 (2020)

Cited On:

Patients Who Develop Recurrent HCV Infection Post Liver Transplantation

Export Citation:

RIS Format

Top